Why the study?
Does an ultrathin bioresorbable-polymer sirolimus-eluting stent reduce periprocedural high-sensitivity cardiac troponin?
Does an ultrathin bioresorbable-polymer sirolimus-eluting stent reduce periprocedural high-sensitivity cardiac troponin?
Answers are grounded in this paper and cite their sources.
A pilot study suggests that an ultrathin bioresorbable-polymer sirolimus-eluting stent may lower periprocedural high-sensitivity cardiac troponin.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: